Dr Todd Hardy

Clinical Senior Lecturer
Medicine, Concord Clinical School

Telephone +61 2 9767 6416

Map

Biographical details

Dr Todd Hardy is a Staff Specialist Neurologist at Concord Hospital, Clinical Senior Lecturer in Medicine at the University of Sydney and Co-Director of the MS Clinic at the Brain & Mind Centre where he is Principal Investigator on a number of MS clinical trials. He is Co-Editor of Advances in Clinical Neuroscience and Rehabilitation.

Research interests

Dr Hardy’s clinical and research interests are in the field of neuroimmunology. His main focus is on multiple sclerosis, including atypical forms of demyelination, and other neuroinflammatory diseases of the central nervous system (CNS), especially Susac’s syndrome.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Morosin, T., Ashford, B., Ranson, M., Hardy, T., Clark, J., Gopalakrishna Iyer, N., Spring, K. (2016). Circulating tumour cells in regionally metastatic cutaneous squamous cell carcinoma: A pilot study. Oncotarget, 7(30), 47111-47115. [More Information]
  • Hardy, T., Tobin, W., Lucchinetti, C. (2016). Exploring the overlap between multiple sclerosis, tumefactive demyelination and Balo's concentric sclerosis. Multiple Sclerosis and Related Disorders, 22(8), 986-992. [More Information]
  • Heiduschka, G., Virk, S., Palme, C., Chng, S., Elliot, M., Hardy, T., Clark, J. (2016). Margin to tumor thickness ratio - A predictor of local recurrence and survival in oral squamous cell carcinoma. Oral Oncology, 55, 49-54. [More Information]
  • Ramanathan, S., Prelog, K., Barnes, E., Tantsis, E., Reddel, S., Henderson, A., Vucic, S., Gorman, M., Benson, L., Alper, G., Barnett, M., Parratt, J., Hardy, T., Merheb, V., Nosadini, M., Fung, V., Brilot-Turville, F., Dale, R., et al (2016). Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Multiple Sclerosis Journal, 22(4), 470-482. [More Information]
  • Rakusa, M., Cano, S., Porter, B., Riazi, A., Thompson, A., Chataway, J., Hardy, T. (2015). A predictive model for corticosteroid response in individual patients with MS relapses. PloS One, 10(3), 1-11. [More Information]
  • Hardy, T., Beadnall, H., Sutton, I., Mohamed, A., Buckland, M., Barnett, M. (2015). Balo's concentric sclerosis and tumefactive demyelination: A shared immunopathogenesis? Journal of the Neurological Sciences, 348(1-2), 279-281. [More Information]
  • Hardy, T., O’Brien, B., Gerbis, N., Barnett, M., Reddel, S., Brewer, J., Herkes, G., Silberstein, P., Garsia, R., Watson, J., Gupta, R., Parratt, J., et al (2015). Brain histopathology in three cases of Susac's syndrome: Implications for lesion pathogenesis and treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 86(5), 582-584. [More Information]
  • Ramanathan, S., Langguth, D., Hardy, T., Garg, N., Bundell, C., Rojana-udomsart, A., Dale, R., Robertson, T., Mammen, A., Reddel, S. (2015). Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy. Neurology: Neuroimmunology and Neuroinflammation, 2(3), 1-8. [More Information]
  • Buzzard, K., Reddel, S., Yiannikas, K., Riminton, S., Barnett, M., Hardy, T. (2015). Distinguishing Susac's syndrome from multiple sclerosis. Journal of Neurology, 262(7), 1613-1621. [More Information]
  • Buzzard, K., Meyer, N., Hardy, T., Riminton, D., Reddel, S. (2015). Induction IV cyclophosphamide followed by maintenance oral immunosuppression in refractory myasthenia gravis. Muscle and Nerve, 52(2), 204-210. [More Information]
  • Garg, N., Reddel, S., Miller, D., Chataway, J., Riminton, S., Barnett, Y., Masters, L., Barnett, M., Hardy, T. (2015). The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases. Journal of Neurology, Neurosurgery, and Psychiatry, 86(12), 1374-1382. [More Information]
  • Hardy, T., Miller, D. (2014). Baló's concentric sclerosis. The Lancet Neurology, 13(7), 740-746. [More Information]
  • Hardy, T., Chataway, J. (2013). Tumefactive demyelination: an approach to diagnosis and management. Journal of Neurology, Neurosurgery and Psychiatry, 84(9), 1047-1053. [More Information]
  • Femia, J., Hardy, T., Spies, J., Horvath, L. (2012). Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: A case report and literature review. Asia-Pacific Journal of Clinical Oncology, 8(2), 115-122. [More Information]
  • Ng, W., Chua, B., Hardy, T., Wechsler, D., Reddel, S. (2011). Bilateral homonymous superior quadrantanopia after traumatic attempts to remove a cockroach impacted in the external auditory canal. Medical Journal of Australia, 194(8), 420-422. [More Information]

2016

  • Morosin, T., Ashford, B., Ranson, M., Hardy, T., Clark, J., Gopalakrishna Iyer, N., Spring, K. (2016). Circulating tumour cells in regionally metastatic cutaneous squamous cell carcinoma: A pilot study. Oncotarget, 7(30), 47111-47115. [More Information]
  • Hardy, T., Tobin, W., Lucchinetti, C. (2016). Exploring the overlap between multiple sclerosis, tumefactive demyelination and Balo's concentric sclerosis. Multiple Sclerosis and Related Disorders, 22(8), 986-992. [More Information]
  • Heiduschka, G., Virk, S., Palme, C., Chng, S., Elliot, M., Hardy, T., Clark, J. (2016). Margin to tumor thickness ratio - A predictor of local recurrence and survival in oral squamous cell carcinoma. Oral Oncology, 55, 49-54. [More Information]
  • Ramanathan, S., Prelog, K., Barnes, E., Tantsis, E., Reddel, S., Henderson, A., Vucic, S., Gorman, M., Benson, L., Alper, G., Barnett, M., Parratt, J., Hardy, T., Merheb, V., Nosadini, M., Fung, V., Brilot-Turville, F., Dale, R., et al (2016). Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Multiple Sclerosis Journal, 22(4), 470-482. [More Information]

2015

  • Rakusa, M., Cano, S., Porter, B., Riazi, A., Thompson, A., Chataway, J., Hardy, T. (2015). A predictive model for corticosteroid response in individual patients with MS relapses. PloS One, 10(3), 1-11. [More Information]
  • Hardy, T., Beadnall, H., Sutton, I., Mohamed, A., Buckland, M., Barnett, M. (2015). Balo's concentric sclerosis and tumefactive demyelination: A shared immunopathogenesis? Journal of the Neurological Sciences, 348(1-2), 279-281. [More Information]
  • Hardy, T., O’Brien, B., Gerbis, N., Barnett, M., Reddel, S., Brewer, J., Herkes, G., Silberstein, P., Garsia, R., Watson, J., Gupta, R., Parratt, J., et al (2015). Brain histopathology in three cases of Susac's syndrome: Implications for lesion pathogenesis and treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 86(5), 582-584. [More Information]
  • Ramanathan, S., Langguth, D., Hardy, T., Garg, N., Bundell, C., Rojana-udomsart, A., Dale, R., Robertson, T., Mammen, A., Reddel, S. (2015). Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy. Neurology: Neuroimmunology and Neuroinflammation, 2(3), 1-8. [More Information]
  • Buzzard, K., Reddel, S., Yiannikas, K., Riminton, S., Barnett, M., Hardy, T. (2015). Distinguishing Susac's syndrome from multiple sclerosis. Journal of Neurology, 262(7), 1613-1621. [More Information]
  • Buzzard, K., Meyer, N., Hardy, T., Riminton, D., Reddel, S. (2015). Induction IV cyclophosphamide followed by maintenance oral immunosuppression in refractory myasthenia gravis. Muscle and Nerve, 52(2), 204-210. [More Information]
  • Garg, N., Reddel, S., Miller, D., Chataway, J., Riminton, S., Barnett, Y., Masters, L., Barnett, M., Hardy, T. (2015). The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases. Journal of Neurology, Neurosurgery, and Psychiatry, 86(12), 1374-1382. [More Information]

2014

  • Hardy, T., Miller, D. (2014). Baló's concentric sclerosis. The Lancet Neurology, 13(7), 740-746. [More Information]

2013

  • Hardy, T., Chataway, J. (2013). Tumefactive demyelination: an approach to diagnosis and management. Journal of Neurology, Neurosurgery and Psychiatry, 84(9), 1047-1053. [More Information]

2012

  • Femia, J., Hardy, T., Spies, J., Horvath, L. (2012). Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: A case report and literature review. Asia-Pacific Journal of Clinical Oncology, 8(2), 115-122. [More Information]

2011

  • Ng, W., Chua, B., Hardy, T., Wechsler, D., Reddel, S. (2011). Bilateral homonymous superior quadrantanopia after traumatic attempts to remove a cockroach impacted in the external auditory canal. Medical Journal of Australia, 194(8), 420-422. [More Information]

To update your profile click here. For support on your academic profile contact .